(Queen Mary University of London) A new test, based on a patient’s epigenetics, could be an accurate and inexpensive way to find and treat those at highest risk of anal cancer — a disease with growing incidence in women, men who have sex with men (MSM) and people with HIV. (Source: EurekAlert! – Cancer)
MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.